Uzbekistan’s pharmaceutical industry is rapidly expanding, driven by strong government support, major infrastructure investments, and growing market demand. The sector’s foreign trade turnover reached $2.6 billion in 2024, with pharmaceutical exports growing by 50% annually.

Five specialized Pharmaceutical Free Economic Zones (FEZs) offer up to 10 years of tax exemptions, duty-free import of raw materials, and some of the lowest operational costs in the region. Average monthly wages range from $300 to $400.

A key infrastructure project, Tashkent Pharma Park, spans 190 hectares with $1.4 billion in investments, combining production facilities, R&D centers, and educational institutions.

With over 2,600 registered pharmaceutical products and 56 GMP-certified companies, Uzbekistan is emerging as a leading pharmaceutical hub in Central Asia, offering investors a dynamic ecosystem and strong market potential.

Uzbekistan offers competitive infrastructure costs, making it an attractive location for manufacturing investments. Key costs include:

- Gas: 12 cents per m³

- Electricity: 7 cents per kWh

- Water: 20 cents per m³

Uzbekistan offers a skilled and cost-effective labor force, ideal for the manufacturing sector. In this field the country has:

- 7 higher education institutions

- 9 faculties

- 1 200 graduates annually

GSP+ agreement allows to export to EU at reduced or zero tariff for 6 200 products. CIS Free Trade Agreement creates more integrated and open market with CIS countries.

Investors in Free Economic Zones (FEZs) can benefit from tax exemptions on land, property, water, and corporate income tax (CIT).

3 years: for investments between 0.3 - 3 million USD

5 years: for investments between 3 - 5 million USD

7 years: for investments between 5 - 10 million USD

10 years: for investments over 10 million USD